Skip to Content

This page is intended for US Healthcare Providers and residents only.

- For 6 months-5 years of age (Primary Series and Bivalent Booster)
- For 6+ years of age (Primary Series and Bivalent Booster)
FDA EUA Letter
Visit spikevax
(COVID-19 vaccine, mRNA)

Moderna COVID-19 Vaccine

Moderna COVID-19 Vaccine

EUA Fact Sheets for Vaccine Providers

Bivalent Booster Dose for
6 months-5 years
Bivalent Booster Dose for
6+ years
Primary Series for
6 months-5 years
Primary Series
for 6-11 years
Primary Series for
12+ years

EUA Fact Sheets for Vaccine Recipients

For 6 months-5 years of age (Primary Series and Bivalent Booster)
For 6+ years of age (Primary Series and Bivalent Booster)

FDA EUA Letter Visit spikevax (COVID-19 vaccine, mRNA)

Sitemap

Home

Vaccine Recipients

Home
What is the Moderna COVID-19 Vaccine
Safety
Who Can Get Vaccinated
FAQs
Multi-Language Resources

Vaccination Providers

Home
About Our Vaccine
Storage and Handling
Dosing and Administration
Clinical Trial Data
Resources
FAQs
How To Look Up Vial Expiration Date
Multi-Language Resources

About Moderna

www.ModernaTX.com

1‑866‑MODERNA (1‑866‑663‑3762)
8:00AM - 8:00PM EST, Monday-Friday
(not including Holidays)

© 2022 ModernaUS-COV-2200342 12/2022
Privacy Policy
Terms of Use
Sitemap

You are about to leave this website

You are now leaving www.modernatx.com, a website provided by Moderna. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. The content displayed on external websites is not controlled by Moderna, and Moderna assumes no responsibility for the information or statements on such external websites.

For Vaccination Providers Only

This website contains information intended for vaccination providers in the United States only and is not intended for the general public.

Yes, I'm a vaccination provider

Introducing Moderna COVID-19 Vaccine, Bivalent for 6 months of age and older

The updated mRNA vaccine from Moderna that can help provide protection against today's COVID-19 variants.

The Emergency Use Authorization (EUA) Fact Sheets for Vaccination Providers have updates related to age group, vial presentation, and dosing. See below for details.

AUTHORIZED USE

Emergency uses of the vaccine have not been approved or licensed by the FDA, but have been authorized by the FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19). The Moderna COVID-19 Vaccine is authorized in individuals 6 months of age and older as a primary series. The Moderna COVID-19 Vaccine, Bivalent is authorized as a booster dose in individuals 6 months through 5 years of age at least 2 months after the Moderna COVID-19 Vaccine primary series and is authorized in individuals 6 years of age and older at least 2 months after any authorized or approved vaccine.
The EUA for these products is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.
For more information on the EUA authorized uses of the vaccine, refer to the Fact Sheets for Healthcare Providers Administering Vaccine (Vaccine Providers) and Full Prescribing Information.

EUA Fact Sheet and full PI for Vaccination Providers, Bivalent Booster Dose for 6 months-5 years of age

EUA Fact Sheet and full PI for Vaccination Providers, Bivalent Booster Dose for 6+ years

Download Guide for Children
6 months - 5 years Dear HCP Letter for Bivalent Booster Doses for ages
6 months - 5 years